153 related articles for article (PubMed ID: 10615786)
21. A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy.
Qian J; Qian Y; Wang J; Gu B; Pei D; He S; Zhu F; Røe OD; Xu J; Liu L; Gu Y; Guo R; Yin Y; Shu Y; Chen X
Drug Des Devel Ther; 2016; 10():241-58. PubMed ID: 26966350
[TBL] [Abstract][Full Text] [Related]
22. Current advances and changes in treatment strategy may improve survival and quality of life in patients with potentially curable gastric cancer.
Roukos DH
Ann Surg Oncol; 1999; 6(1):46-56. PubMed ID: 10030415
[TBL] [Abstract][Full Text] [Related]
23. [Results of the surgical treatment of cancer of the cardia].
Fékété F; Sauvanet A; Berthoux L; Flejou JF; Gayet B
J Chir (Paris); 1997 Nov; 134(5-6):202-8. PubMed ID: 9772973
[TBL] [Abstract][Full Text] [Related]
24. [Surgical outcome of 801 patients with localized gastric cancer treated with d2 lymphadenectomy].
Ruiz E; Sanchez J; Celis J; Payet E; Berrospi F; Chavez I; Young F
Rev Gastroenterol Peru; 2009; 29(2):124-31. PubMed ID: 19609327
[TBL] [Abstract][Full Text] [Related]
25. [Stage-adapted radical principles in gastric carcinoma].
Verreet PR
Praxis (Bern 1994); 1998 Mar; 87(13):447-50. PubMed ID: 9584570
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors in the surgical treatment of gastric cancer--10 years experience.
Káposztás Z; Kalmár K; Cseke L; Illényi L; Kelemen D; Horváth OP
Magy Seb; 2007 Apr; 60(2):71-8. PubMed ID: 17649847
[TBL] [Abstract][Full Text] [Related]
27. Outcome of patients with proximal gastric cancer depends on extent of resection and number of resected lymph nodes.
Volpe CM; Driscoll DL; Douglass HO
Ann Surg Oncol; 2000 Mar; 7(2):139-44. PubMed ID: 10761793
[TBL] [Abstract][Full Text] [Related]
28. Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake?
Reddavid R; Sofia S; Chiaro P; Colli F; Trapani R; Esposito L; Solej M; Degiuli M
World J Gastroenterol; 2018 Jan; 24(2):274-289. PubMed ID: 29375213
[TBL] [Abstract][Full Text] [Related]
29. Surgical outcomes for gastric cancer in the upper third of the stomach.
Kim JH; Park SS; Kim J; Boo YJ; Kim SJ; Mok YJ; Kim CS
World J Surg; 2006 Oct; 30(10):1870-6; discussion 1877-8. PubMed ID: 16957826
[TBL] [Abstract][Full Text] [Related]
30. Robotic distal subtotal gastrectomy with D2 lymphadenectomy for gastric cancer patients with high body mass index: comparison with conventional laparoscopic distal subtotal gastrectomy with D2 lymphadenectomy.
Lee J; Kim YM; Woo Y; Obama K; Noh SH; Hyung WJ
Surg Endosc; 2015 Nov; 29(11):3251-60. PubMed ID: 25631106
[TBL] [Abstract][Full Text] [Related]
31. [Discussion on standardized implementation of laparoscopic radical lymphadenectomy for distal gastric cancer].
Lyu Z; Wang J; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Aug; 20(8):857-861. PubMed ID: 28836242
[TBL] [Abstract][Full Text] [Related]
32. Laparoscopic and robot-assisted gastrectomy for gastric cancer: Current considerations.
Caruso S; Patriti A; Roviello F; De Franco L; Franceschini F; Coratti A; Ceccarelli G
World J Gastroenterol; 2016 Jul; 22(25):5694-717. PubMed ID: 27433084
[TBL] [Abstract][Full Text] [Related]
33. [Gastric cancer - current state of the problem (II part). Surgical treatment of gastric cancer ( stage IB, II, IIIA)].
Bulanov D
Khirurgiia (Sofiia); 2007; (5):45-52. PubMed ID: 18580834
[TBL] [Abstract][Full Text] [Related]
34. [Prognosis analysis of surgical treatment for cancer of stomach fundus and cardia with invasion to body and tail of the pancreas].
Huang CM; Lu HS; Li P; Xie JW; Lin BJ; Zhang XF
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):432-5. PubMed ID: 18803043
[TBL] [Abstract][Full Text] [Related]
35. Gastric cancer in the elderly: an overview.
Saif MW; Makrilia N; Zalonis A; Merikas M; Syrigos K
Eur J Surg Oncol; 2010 Aug; 36(8):709-17. PubMed ID: 20542657
[TBL] [Abstract][Full Text] [Related]
36. Shifting proportions of gastric adenocarcinomas.
Salvon-Harman JC; Cady B; Nikulasson S; Khettry U; Stone MD; Lavin P
Arch Surg; 1994 Apr; 129(4):381-8; discussion 388-9. PubMed ID: 7512326
[TBL] [Abstract][Full Text] [Related]
37. [Extended Pathohistological Criteria for Assessment of the Long-Term Prognosis of Gastric Cancer].
Dittmar Y; Rauchfuss F; Dondorf F; Ardelt M; Scheuerlein H; Settmacher U
Zentralbl Chir; 2016 Aug; 141(4):433-41. PubMed ID: 25723861
[TBL] [Abstract][Full Text] [Related]
38. Influence of surgery on outcomes in gastric cancer.
Hartgrink HH; Bonenkamp HJ; van de Velde CJ
Surg Oncol Clin N Am; 2000 Jan; 9(1):97-117, vii-viii. PubMed ID: 10601527
[TBL] [Abstract][Full Text] [Related]
39. Is D2 lymphadenectomy in gastrectomy safe with regard to the skill of the operator?
Moriwaki Y; Kobayashi S; Kunisaki C; Harada H; Imai S; Kido Y; Kasaoka C
Dig Surg; 2001; 18(2):111-7. PubMed ID: 11351155
[TBL] [Abstract][Full Text] [Related]
40. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
Anticancer Res; 2000; 20(2B):1285-9. PubMed ID: 10810436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
